LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

10X Genomics Inc (Class A)

Închisă

SectorSănătate

10.39 -1.89

Rezumat

Modificarea prețului

24h

Curent

Minim

10.29

Maxim

10.42

Indicatori cheie

By Trading Economics

Venit

15M

-34M

Vânzări

-10M

155M

EPS

-0.102

Marjă de profit

-22.183

Angajați

1,306

EBITDA

-1.5M

-39M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+22.87% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

100M

1.2B

Deschiderea anterioară

12.28

Închiderea anterioară

10.39

Sentimentul știrilor

By Acuity

34%

66%

98 / 381 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

10X Genomics Inc (Class A) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 iun. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Millicom to Acquire Telefonica Ecuador for $380 Million

14 iun. 2025, 01:24 UTC

Achiziții, Fuziuni, Preluări

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13 iun. 2025, 23:50 UTC

Achiziții, Fuziuni, Preluări

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13 iun. 2025, 23:20 UTC

Achiziții, Fuziuni, Preluări

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13 iun. 2025, 23:09 UTC

Achiziții, Fuziuni, Preluări

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13 iun. 2025, 23:03 UTC

Achiziții, Fuziuni, Preluări

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13 iun. 2025, 22:18 UTC

Achiziții, Fuziuni, Preluări

Millicom to Acquire Telefonica Ecuador for $380M

13 iun. 2025, 22:04 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Better Data Facilitate Investments In Oil Patch -- Market Talk

13 iun. 2025, 21:42 UTC

Achiziții, Fuziuni, Preluări

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 iun. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Bunge: Outside Date Extended to July 3

13 iun. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

13 iun. 2025, 21:34 UTC

Achiziții, Fuziuni, Preluări

Bunge Gets Mexico Approval for Viterra Deal

13 iun. 2025, 21:32 UTC

Achiziții, Fuziuni, Preluări

Bunge Gets China Approval for Viterra Deal

13 iun. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

13 iun. 2025, 20:45 UTC

Achiziții, Fuziuni, Preluări

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 iun. 2025, 20:34 UTC

Achiziții, Fuziuni, Preluări

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 iun. 2025, 20:14 UTC

Achiziții, Fuziuni, Preluări

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 iun. 2025, 20:14 UTC

Achiziții, Fuziuni, Preluări

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 iun. 2025, 20:14 UTC

Achiziții, Fuziuni, Preluări

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

13 iun. 2025, 19:30 UTC

Market Talk

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

13 iun. 2025, 19:12 UTC

Market Talk

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

13 iun. 2025, 19:04 UTC

Market Talk

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

13 iun. 2025, 18:54 UTC

Market Talk

Correction to Gold Settles Market Talk

13 iun. 2025, 18:01 UTC

Market Talk

Gold Settles at Record High -- Market Talk

13 iun. 2025, 17:40 UTC

Market Talk

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

13 iun. 2025, 17:21 UTC

Market Talk

Dollar Index, Commodities Rise -- Market Talk

13 iun. 2025, 17:02 UTC

Achiziții, Fuziuni, Preluări

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

13 iun. 2025, 17:02 UTC

Achiziții, Fuziuni, Preluări

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

13 iun. 2025, 17:02 UTC

Achiziții, Fuziuni, Preluări

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

13 iun. 2025, 17:02 UTC

Achiziții, Fuziuni, Preluări

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

Comparație

Modificare preț

10X Genomics Inc (Class A) Așteptări

Obiectiv de preț

By TipRanks

22.87% sus

Prognoză pe 12 luni

Medie 13 USD  22.87%

Maxim 18 USD

Minim 9 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentru10X Genomics Inc (Class A) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

4

Cumpărare

6

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

8.32 / 8.63Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

98 / 381 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.